Patents Assigned to RDD Pharma Ltd.
  • Patent number: 10821274
    Abstract: A device for drug delivery to an orifice of a subject, comprising a shell which is elastically stressed by an active pharmaceutical ingredient, said shell containing and being substantially impermeable to said active pharmaceutical ingredient, wherein said shell has at least one hole sized for in-vivo release of said active pharmaceutical ingredient as a result of elastic stressing.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: November 3, 2020
    Assignee: RDD PHARMA LTD.
    Inventor: Nir Barak
  • Patent number: 9937136
    Abstract: Methods of preventing, ameliorating and/or treating radiation induced gastrointestinal tract injury comprising the administration of a therapeutically effective amount of Mesna to a patient are provided. Methods for preventing, treating and/or ameliorating gastrointestinal tract injury induced by radiation therapy, alone or in combination with other therapies for diseases or conditions such as gastrointestinal malignancies, urogenital malignancies, gynecologic malignancies, and osteogenic and other sarcomatous malignancies in which pelvic structures are involved.
    Type: Grant
    Filed: November 16, 2014
    Date of Patent: April 10, 2018
    Assignee: RDD PHARMA LTD.
    Inventor: Nir Barak
  • Patent number: 9849114
    Abstract: Methods for treating fecal incontinence by administering to a subject in need thereof compositions including oxymetazoline as an active ingredient. Kits including compositions of oxymetazoline suitable for topical application, for the treatment of fecal incontinence.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: December 26, 2017
    Assignee: RDD Pharma Ltd.
    Inventors: Nir Barak, Howard Lawrence Rice
  • Publication number: 20160279082
    Abstract: Methods of preventing, ameliorating and/or treating radiation induced gastrointestinal tract injury comprising the administration of a therapeutically effective amount of Mesna to a patient are provided. Methods for preventing, treating and/or ameliorating gastrointestinal tract injury induced by radiation therapy, alone or in combination with other therapies for diseases or conditions such as gastrointestinal malignancies, urogenital malignancies, gynecologic malignancies, and osteogenic and other sarcomatous malignancies in which pelvic structures are involved.
    Type: Application
    Filed: November 16, 2014
    Publication date: September 29, 2016
    Applicant: RDD PHARMA LTD.
    Inventor: Nir BARAK
  • Publication number: 20160271110
    Abstract: Methods for treating fecal incontinence by administering to a subject in need thereof compositions including oxymetazoline as an active ingredient. Kits including compositions of oxymetazoline suitable for topical application, for the treatment of fecal incontinence.
    Type: Application
    Filed: May 31, 2016
    Publication date: September 22, 2016
    Applicant: RDD Pharma Ltd.
    Inventors: Nir Barak, Howard Lawrence Rice
  • Publication number: 20140228782
    Abstract: A device for drug delivery to an orifice of a subject, comprising a shell which is elastically stressed by an active pharmaceutical ingredient, said shell containing and being substantially impermeable to said active pharmaceutical ingredient, wherein said shell has at least one hole sized for in-vivo release of said active pharmaceutical ingredient as a result of elastic stressing.
    Type: Application
    Filed: April 21, 2014
    Publication date: August 14, 2014
    Applicant: RDD Pharma Ltd.
    Inventor: Nir Barak
  • Patent number: 8734826
    Abstract: A rectally insertable device for localized drug delivery to the anal sphincter of a subject, a method of using the device and the use of the device is disclosed. The device comprises a shell for containing an active pharmaceutical ingredient, the shell being substantially impermeable to the active pharmaceutical ingredient wherein a lower portion of the shell is configured to release the active pharmaceutical ingredient from the shell and wherein when the device is inserted into the rectum of the subject, the lower portion of the shell is proximal to the anal sphincter, such that the active pharmaceutical ingredient is released proximal to the anal sphincter.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: May 27, 2014
    Assignee: RDD Pharma, Ltd.
    Inventor: Nir Barak
  • Patent number: 8715706
    Abstract: A device for drug delivery to an orifice of a subject, comprising a shell which is elastically stressed by an active pharmaceutical ingredient, said shell containing and being substantially impermeable to said active pharmaceutical ingredient, wherein said shell has at least one hole sized for in-vivo release of said active pharmaceutical ingredient as a result of elastic stressing.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: May 6, 2014
    Assignee: RDD Pharma, Ltd.
    Inventor: Nir Barak
  • Patent number: 8686040
    Abstract: The invention relates to methods and compositions for the treatment of pruritis ani and other perianal disorders. There are currently few treatments for these conditions, many of which have significant side effects. The methods of the invention involve the administration, in a cream or lotion of pregabalin, an anti-epileptic agent that has pain relieving properties. This topical form of pregabalin may also include the addition of other agents such as immunomodulators, antibiotics or agents that enhance wound healing. This method may be useful as a new and safe treatment for pruritis ani, skin conditions and other anorectal disorders. Previous positive clinical experience suggests that this new treatment is promising for these disorders.
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: April 1, 2014
    Assignee: RDD Pharma Ltd.
    Inventor: Eli D Ehrenpreis